ARCHIVES

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

New Publications

January 20, 1989

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

CTEP-Approved Trials For the Month of June

June 28, 2013

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008

DeVita Considers Laetrile Tests

June 3, 1977